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ABSTRACT
Background: Promoting and maintaining health is critical to ruminant welfare and
productivity. Within human medicine, faecal lactoferrin is quantified for routine
assessment of various gastrointestinal illnesses avoiding the need for blood sampling.
This approach might also be adapted and applied for non-invasive health
assessments in animals.
Methods: In this proof-of-concept study, a bovine lactoferrin enzyme-linked
immunosorbent assays (ELISA), designed for serum and milk, was applied to a faecal
supernatant to assess its potential for quantifying lactoferrin in the faeces of cattle.
Faecal lactoferrin concentrations were compared to background levels to assess the
viability of the technique. A comparison was then made against serum lactoferrin
levels to determine if they were or were not reflective of one another.
Results: The optical densities of faecal samples were significantly greater than
background readings, supporting the hypothesis that the assay was effective in
quantifying faecal lactoferrin (T13, 115 = 11.99, p < 0.0005). The mean faecal
lactoferrin concentration was 0.269 µg mL−1 (S.E. 0.031) and the mean serum
concentration 0.074 µg mL−1 (S.E. 0.005). Lactoferrin concentrations of faecal and
serum samples, taken from the same animals on the same day, were significantly
different (T21 = 2.20, p = 0.039) and did not correlate (r = 0.2699, p = 0.238).
Conclusion: Results support the hypothesis that lactoferrin can be quantified in
cattle faeces by ELISA. Whilst further research is required to determine the
physiological source of the lactoferrin, this highlights the potential of the method for
non-invasive assessment of cattle immunology and pathology.
Subjects Agricultural Science, Ecology, Veterinary Medicine, Zoology
Keywords One-health, Livestock, Veterinary science, Animals, Immunology, Ecology, Agriculture,
Veterinary medicine, Zoology
INTRODUCTION
Ruminant health is central to ensuring animal welfare and to facilitating productivity and
sustainability in commercial ruminant systems. Inflammation, particularly at the intestinal
barrier, can be symptomatic of poor health and cause significant welfare and economic
losses through reduced feed conversion and productivity (Beever & Doyle, 2007; Charlier
et al., 2009; Khiaosa-ard & Zebeli, 2014; Niezen et al., 1995; VandeHaar & St-Pierre, 2006).
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Kvidera et al. (2017) found that a compromised intestinal barrier, causing inflammation,
significantly reduced feed intake and milk yields in dairy cattle, in beef cattle this
would likely result in a reduction in weight gain, with an economic cost. As worldwide
demand for meat increases (Fiala, 2008), along with pressures on the natural resources
that support its production (Gordon et al., 2017), it is essential that gut health is optimised
to improve the efficiency and sustainability of livestock production systems. This calls
for the urgent development of economically viable tools for the rapid diagnosis of gut
disease, to support prevention and rapid correction of poor gut function.
Recently, Watt et al. (2016) and Cooke et al. (2019) both demonstrated that
enzyme-linked immunosorbent assays (ELISA), designed for use on serum and milk, can
be utilised for quantifying anti-parasite antibodies in the faeces of sheep and cattle,
through the use of a novel faecal supernatant (Watt et al., 2016; Cooke et al., 2019).
This suggests the possibility of quantifying other immunological proteins in faeces.
Such techniques can provide valuable insights into the health of livestock, particularly in
relation to parasitic diseases and potentially gastrointestinal health in general. Another
advantage of faeces-based methods is that samples can be collected non-invasively and
without negative impacts on welfare. Wider potential benefits include the immunological
assessment of animals that cannot be directly sampled, for example, if they are evasive
or dangerous.
Lactoferrin is an inflammatory marker and key indicator of gut damage. Lactoferrin
binds to iron, preventing its utilisation by bacteria and producing a bacteriostatic effect
(Weinberg, 1984). For example, Kieckens et al. (2015) found that rectal administration
of lactoferrin to calves significantly reduced Escherichia coli counts. Furthermore,
lactoferrin can regulate immune responses against infection, preventing inflammation by
modulating immune cell function, migration and maturation (Kruzel, Zimecki & Actor,
2017; Legrand et al., 2005). Although predominantly found at mucosal surfaces,
lactoferrin can be detected in milk and serum (Sánchez, Calvo & Brock, 1992). In human
medicine, faecal lactoferrin is used as an inflammatory marker in the diagnosis of
gastrointestinal conditions such as inflammatory bowel diseases and Crohn’s disease
(Gisbert et al., 2009; Lamb & Mansfield, 2011; Lundberg et al., 2005; Tibble et al., 2000).
This is due to the localised expression of lactoferrin throughout the body. One key site of
lactoferrin expression is by epithelial cells for secretion to mucosal surfaces (Ward, Paz &
Conneely, 2005), such as those lining the intestinal tracts of mammals. However,
lactoferrin is also present in other parts of the body such as hepatocytes (Oh et al., 1997)
and blood cells (Bennett & Kokocinski, 1978). Despite lactoferrin analysis being common
place in human medicine, quantification of lactoferrin is not routinely conducted
within veterinary medicine, other than for the analysis of bulk-tank milk (Nielsen et al.,
2000; Parker et al., 2017; Stabel, Wells & Wagner, 2002; Thobokwe, Heuer & Hayes, 2004).
The purpose of this study is to evaluate the feasibility of quantifying lactoferrin in
ruminant faeces using techniques analogous to those presented by Watt et al. (2016) and
Cooke et al. (2019). That is, to assess if lactoferrin can be quantified in the faeces of
ruminants by using a commercially feasible ELISA product, designed for serum and milk,
with a specialised faecal supernatant.
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METHODS
Sample populations
Faecal samples were collected from three herds of beef cattle located in Cornwall, Angus,
and Hertfordshire in the UK (C1, C2 and C3 respectively). Across the groups, cattle
included calves, cows, heifers and steers. Groups C1 and C3 were fed on grass silage for at
least 1 month prior to sampling and group C2 was permanently grazed on pasture. Group
C1 were Aberdeen Angus crossed with Belgian Blue and Holstein. Group C2 were all
Aberdeen Angus crossed with Hereford and Galloway. Group C3 were the Sussex breed.
A total of 117 faecal samples were collected from the three farms (65, 30 and 22 from
C1, C2 and C3 respectively), and 22 blood samples were collected from C3. Sample
numbers were based on availability, gathering the most feasible from each farm. Cattle had
no known or visually obvious signs of illness or infirmity at the time of sampling, however
individual animal health differences were not a focus of the study and clinical health
assessments were not conducted.
Access to study sites was permitted by the landowner/manager. Permissions for the
cattle sites were obtained by Andrew Cooke (Rothamsted Research) and permissions for
the sheep and deer sites were obtained by the University of Edinburgh.
All cattle blood samples were taken by a trained and qualified veterinary surgeon who
was conducting routine analysis in support of animal health under the UK Veterinary
Surgeons Act 1966. Samples were analysed on request of the veterinary surgeon using
excess samples and did not require excess blood being drawn in addition to what was
required under routine practice. Sheep blood samples were taken under the Animal
Scientific Procedures Act (1986). Samples used in this study were remnant samples taken
under project license no: PPL 60/4211, personal license no: PIL 60/623. The single deer
blood sample was taken with the landowner’s permission from an animal shot for food.
Some sheep and deer samples (faeces and blood) were available from other experiments
and were analysed as an additional data set. No commercially feasible lactoferrin
ELISA was available for analysis of those samples, so they were subject to the bovine
lactoferrin ELISA protocol. Further details of the analysis of sheep and deer samples are
available in the Supplemental Material.
Sample collection and preparation
Faecal samples
Fresh faeces were collected from the ground immediately after defecation was observed.
Faecal samples were stored in screw-top 100 mL plastic containers and stored at −18 C
until processing. Samples were defrosted at room temperature and mixed with a protease
inhibitor (cOmpleteTM, EDTA-free Protease Inhibitor Cocktail, Roche, Germany) at a
ratio of 1:1–1:2 (w:v) with phosphate-buffered saline, as per the manufacturers protocol,
depending upon consistency and moisture. This mixture was homogenised and
centrifuged at 3–6 C and 12,000×g (Sorvall SLA-3000 rotor in a Sorvall RC-5B centrifuge,
ThermoFisher Scientific, Waltham, MA, USA) for 5 min. The faecal supernatant was then
removed by pipette and stored at −18 C.
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Blood samples
Blood samples were collected by tail venipuncture into glass Vacutainers (Becton
Dickinson, Franklin Lakes, NJ, USA). Samples were left >30 min to clot and were
centrifuged at 1,056×g (Sorvall SLA-3000 rotor in a Sorvall RC-5B centrifuge) for 15 min
to separate serum, which was removed by pipette and stored at −18 C.
Serial dilutions
Test plates were conducted to determine the optimum concentration of faecal
supernatants and serum (diluted with Tris-buffer saline with 0.05% TweenTM 20 (TBST))
to achieve optical densities within the detection limits of the plate reader (Spectramax M2)
and to best show the variation in the datasets. The optimum dilution was qualitatively
determined as the dilution at which no notable plateauing or data clumping had begun,
which can both be features of more dilute samples. If two dilutions presented similar
qualities, the least concentrated was chosen to ensure the capture of lactoferrin samples
higher than those on the trial plates and to preserve sample quantity. Test plates were
conducted on 63 cattle faecal samples at concentrations of 1/1, 1/2, 1/8 and 1/32 and on 22
cattle serum samples at concentrations of 1/5, 1/10, 1/20 and 1/40.
On each plate, a seven-point halving series dilution of bovine lactoferrin standard was
included (Bethyl Laboratories; RC10-126-8) for reference and as a positive control (derived
from bovine colostrum (L4765; Merck, Darmstadt, Germany)). Stock solution was
1,000 µg mL−1, and for the first standard in the series was diluted to 0.5 µg mL−1 with
TBST. Subsequent dilutions added 500 µL of the previous solution in the series to 500 µL of
TBST. Each plate also included three negative control blanks of TBST.
ELISA protocol
The ELISA was conducted using a commercially available bovine lactoferrin ELISA set
(E10-126B; Bethyl Laboratories Inc., Montgomery, TX, USA) which is produced primarily
for use on bovine milk samples. The specified limit of detection for the product is
7.8–500 ng ml−1. The manufacturers protocol was followed as closely as possible, including
the use of the specified buffers and reagents.
The plate coat was made by mixing affinity purified antibody (A10-126A; Bethly
Laboratories Inc., Montgomery, TX, USA) with carbonate buffer at a ratio of 1:100 (v:v).
Then, 100 µL of the formed coat was added to each well and the plates (Nunc–Immuno
Maxsorp 96-well) were covered in cling film and incubated at 20 C for 1 h.
After the first incubation, the plates were washed five times with TBST using an automated
plate washer (Skan Washer 400). A total of 200 µL of TBST was added to each well as a
blocking solution and plates were covered in cling film and incubated at 20 C for 30 min.
After the second incubation, the plates were washed five times in TBST before 100 µL of
sample was added to each well (except blanks) and plates were covered in cling film and
incubated at 20 C for 1 h.
After the third incubation, the plates were washed five times in TBST before 100 µL of
horseradish peroxidase (HRP) detection (0.5% with carbonate buffer) antibody was added
to each well and the plates were covered in cling film and incubated at 20 C for 1 h.
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After the fourth incubation, the plates were washed five times in TBST before 100 µL of
enzyme-substrate (SureBlueTM TMB Microwell Peroxidase Substrate Kit, SeraCare,
Milford, MA, USA) was added to each well before the plates were placed in opaque boxes
and incubated at 20 C for 15 min. Then, 100 µL of stop solution, 0.18 mH2SO4, was added
to each well and plates were immediately read for optical density at 450 nm by a plate
reader, detecting the interaction of the enzyme and substrate.
Statistical analysis
All statistical analyses were performed to a confidence level of 95% in Minitab 18 (Minitab
Ltd., Coventry, UK). Two-sample T-tests were used to determine if faecal supernatant ODs
were significantly above background levels (TBST blanks). Pearson’s correlations were
performed to determine if the test results for serum and faecal samples, matched per
individual and taken on the same day, were correlated. A Pearson’s correlation was also
performed to assess if faecal sample moisture correlated to lactoferrin concentration.
The limit of detection (LoD) (Tholen, 2004; Armbruster & Pry, 2008) was calculated
through the limit of blanks (LoB) using optical density values of blanks and reference
material as:
LoB ¼ meanblanks þ 1:645 ðSDblanksÞ
LoD ¼ LoBþ 1:645 ðSDlow concentration sampleÞ
The low concentration sample used was the lowest concentration serial dilution of
reference material which was at a concentration of 0.007815 µg mL−1. The optical density
generated was then converted to an estimated lactoferrin concentration by interpolating
the LoD optical density onto the mean reference curve of all plates through a
four-parameter sigmoidal curve.
RESULTS
Controls, references and calibration
Negative controls of TBST were consistent across all plates and had a mean background
optical density of 0.0486, ranging from 0.0467 to 0.0506, with a relative standard error of
0.77%. Reference material gave calibration consistent curves with a mean relative standard
error of 1.51% across all dilutions.
Based on the results of three initial test plates, it was determined that a sample
concentration of 50% (v:v with TBST) was optimum for cattle faecal samples. At this
dilution, all samples yielded optical densities significantly above background levels, as
determined using 2-sample T-tests that compared background levels to faecal supernatants
(T13, 115 = 11.99, p < 0.0005) (Fig. 1).
Lactoferrin concentrations
The mean lactoferrin concentration across all faecal samples was 0.269 µg mL−1 (Fig. 2).
The relative standard error was 0.031 and the coefficient of variance 1.236. For serum
samples, the mean concentration was 0.074 µg mL−1 (Fig. 3). The relative standard error
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was 0.005 and the coefficient of variance was 0.314. A paired T-test comparing matched
faecal and serum samples from the same individuals, taken on the same day, found a
statistically significant difference between serum and faecal lactoferrin (T21 = 2.20,
p = 0.039). Furthermore, no statistically significant correlation was found between faecal
Figure 1 Bar chart showing average optical densities, after ELISA process, of faecal, serum and TBST
blank samples. Error bars represent standard error. Full-size DOI: 10.7717/peerj.8631/fig-1
Figure 2 Violin plot showing the distribution of faecal lactoferrin concentrations (µg mL−1) of faecal
samples from cattle (n = 115). The solid black line indicated the median value. The two dashed lines
represent the 1st and 3rd quartiles respectively. The width of the plot at any given point represents the
frequency of values in that region of the plot. Full-size DOI: 10.7717/peerj.8631/fig-2
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and serum lactoferrin concentrations taken from the same individuals on the same day
(r = 0.269, p = 0.238).
The LoD of faecal samples generated an optical density of 0.0561, which was
interpolated as a lactoferrin concentration of 0.0025 µg ml−1.
DISCUSSION
The optical densities of faecal and blood samples, isolated according to the extraction
methods, significantly exceeded those from blank controls (TBST), showing active binding
of the capture antibody during the assay. It is, therefore, concluded that the ELISA protocol
was successful for the detection of lactoferrin in faeces of cattle through the use of a
faecal supernatant. Sheep and deer samples taken in Scotland (see Supplemental Material)
also provided optical densities significantly above background levels, however to a lower
extent than the cattle faecal samples. Whilst this may be a genuine difference, it may
be due to sub-optimal binding of non-bovine lactoferrin to a bovine-specific assay, further
supporting the validity of the assay to specifically detect lactoferrin. We, therefore, accept
the hypothesis that lactoferrin can be quantified in the faeces of ruminants using
commercially available ELISA products. However, cross-species ELISAs are likely to have
reduced avidity and therefore results between different species should not be compared if
using the same ELISA, whilst also having a potentially reduced limit of detection.
The lack of correlation between faecal and serum lactoferrin, taken from the same
individuals on the same day, suggests that faecal lactoferrin quantification is unlikely to be
a suitable proxy for systemic lactoferrin. It may be the case that the faecal lactoferrin
detected originated from a different localised physiological source to the serum lactoferrin.
Figure 3 Violin plot showing the distribution of serum lactoferrin concentrations (µg mL−1) from
cattle (n = 22). The solid black line indicated the median value. The two dashed lines represent the
1st and 3rd quartiles respectively. The width of the plot at any given point represents the frequency of
values in that region of the plot. Full-size DOI: 10.7717/peerj.8631/fig-3
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Therefore, their relative abundances would not be expected to correlate. This would
indicate the potential for future research to determine what source faecal lactoferrin is
representative of. One candidate is the mucosal lining of the gastrointestinal tract, which
would mean that faecal lactoferrin may be an indicator of gastrointestinal health and
pathology. Variation in localised lactoferrin expression has been previously described for
lactoferrin production in the human body (Adlerova, Bartoskova & Faldyna, 2008; Levay &
Viljoen, 1995), though literature is limited for ruminants. It is important to consider that
the structure of lactoferrin varies throughout the body and that the assay used was
designed for milk and serum and therefore the avidity of faecal lactoferrin, depending on
its source, may be sub-optimal. However, assuming the source of faecal lactoferrin is
different to that of milk and serum, this is not an issue so long as the assays avidity to faecal
lactoferrin is consistent and that faecal lactoferrin data is only used comparatively to other
faecal lactoferrin data. Confirmation of the gut as the physiological source of the lactoferrin
in the faeces of ruminants could be achieved by taking swab samples for analysis along
gastrointestinal transects of recently slaughtered individuals and comparison with
matched faecal samples taken immediately prior to death. However, the contrasting
chemistries of ruminant faeces and blood and the manner in which lactoferrin reacts to
different organic and inorganic molecules may affect the successful extraction of the
immune-marker from the different substrates. For example, inconsistent avidity of the
ELISA to different physical forms of lactoferrin has been identified (Bagby & Bennett, 1982;
Bennett, Bagby & Davis, 1981; Kanyshkova, Buneva & Nevinsky, 2001; Mantel,
Miyazawa & Broxmeyer, 1994).
Based on the complexities related to the presentation of lactoferrin in faeces, future
methodological development should include a comparison with complementary
established techniques in molecular biology that detect specific proteins, for example,
western blot and mass spectroscopy, to ratify the results obtained by ELISA to establish its
reliability. However, lactoferrin ELISAs are established and recognised (Hetherington,
Spitznagel & Quie, 1983), and widely used to quantify human lactoferrin in faeces
(Gisbert et al., 2009; Lamb & Mansfield, 2011; Buderus et al., 2004) and bovine lactoferrin
in milk and serum (Cheng et al., 2008), supporting the potential for the use of this
technique for quantifying bovine faecal lactoferrin. The purpose of this study was to
determine the feasibility of the technique and therefore detailed individual animal health
measurements were not taken. Now that evidence for feasibility has been achieved, further
advancement could be made through the sampling of cattle in a range of different
health conditions, particularly those with known gastrointestinal pathogens/diseases such
as coccidiosis and gastrointestinal helminth infections. This would provide information as
to the practical use of the assay as a diagnostic tool.
This study highlights the need and opportunity for the development of testing methods
to assess animal health using faeces, as opposed to blood and milk, as the testing material.
Other biomarkers may be suitable for analogous work, particularly biomarkers such as
calprotectin (Gisbert et al., 2009; Lamb & Mansfield, 2011; Lundberg et al., 2005) and
haptoglobin (Kvidera et al., 2017; Quaye, 2008).
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CONCLUSION
The objective of this research was to assess the feasibility of quantifying lactoferrin in the
faeces of cattle using a specialised faecal supernatant. This objective was met, and the assay
deemed feasible. Whilst prior work using faecal supernatants has focused on antibodies,
the results with lactoferrin results promote the utility of a faecal supernatant as a useful
substrate for quantifying a wider range of biomolecules. This also opens the potential
future development of using faecal lactoferrin as a health indicator in ruminants. However,
this research is only a preliminary step towards that and achieving such would require
significant further work to better understand the mechanisms involved.
The development of a rapid and non-invasive test for the gut health of ruminants using
faecal lactoferrin quantification has potentially wide-reaching benefits. Immunological
assessments of mammals are typically invasive and can be logistically difficult due to
animal aggression, evasiveness and animal welfare legislation. Faecal sampling, therefore,
offers an opportunity for the wide-ranging assessment of gut health in mammals.
This study trialled an existing ELISA, developed to quantify lactoferrin concentrations
in milk, using the supernatant of cattle faeces from three geographically distinct regions of
the UK. There was no relationship between the concentrations of lactoferrin in faecal
supernatant and serum, suggesting different metabolic sources of lactoferrin, or differences
in the success of lactoferrin extraction from two different substrates, which requires further
work to identify. Therefore, faecal lactoferrin may provide novel information that can
provide new insight into animal health. Robust interpretation of faecal lactoferrin ELISA
results will require substantial future work. Nevertheless, this successful proof-of-concept
highlights how lactoferrin and potentially other immune-markers, can be quantified
non-invasively.
ABBREVIATIONS
ANOVA analysis of variance
EDTA ethylenediaminetetraacetic acid
ELISA enzyme-linked immunosorbent assay
GIN gastrointestinal nematode(s)
H2SO4 sulfuric acid
HRP horseradish peroxidase
OD optical density
TBST tris-buffered saline with Tween 20
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